Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 7, 2012, Pages 3663-3672

  Jirarattanasopa, Pichai ^a,b   Ooto, Sotaro ^a   Nakata, Isao ^a   Tsujikawa, Akitaka ^a   Yamashiro, Kenji ^a   Oishi, Akio ^a   Yoshimura, Nagahisa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; RANIBIZUMAB; VERTEPORFIN; DNA; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CAPILLARY PERMEABILITY; CHOROIDAL THICKNESS; CHOROIDAL VASCULAR HYPERPERMEABILITY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPING TECHNIQUE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MAJOR CLINICAL STUDY; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; CHOROID; COMPARATIVE STUDY; EYE FUNDUS; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HYPERTROPHY; INTRAVITREAL DRUG ADMINISTRATION; MALE; METABOLISM; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROGNOSIS; RETINA MACULA DEGENERATION; VASCULARIZATION;

AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; CAPILLARY PERMEABILITY; CHOROID; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; DNA; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTROPHY; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; OPHTHALMOSCOPY; PHOTOCHEMOTHERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84865642319     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-9619     Document Type: Article

References (37)

1. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15-22
2. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina. 1990;10: 1-8
3. Otani A, Sasahara M, Yodoi Y, et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2007;114:7-14
4. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T; ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology. 2009;116:57-65
5. Saito M, Iida T, Nagayama D. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Br J Ophthalmol. 2008; 92:1642-1647
6. Gomi F, Sawa M, Sakaguchi H, et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2008;92:70-73
7. Kokame GT, Yeung L, Lai JC. Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: 6- month results. Br J Ophthalmol. 2010;94:297-301
8. Guyer DR, Yannuzzi LA, Slankter JS, et al. Digital indocyanine green angiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057-1062
9. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina. 1994;14:231-242
10. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996;16:203-213
11. Iida T, Kishi S, Hagimura N, et al. Persistence and bilateral choroidal vascular abnormality in central serous chorioretinopathy. Retina. 1999;19:508-512
12. McLeopod DS, Taomoto M, Otsuji T, et al. Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2002;43: 1986-1993
13. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol. 2006;142:601-607
14. Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina. 2010;30:801-809
15. Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500
16. Margolis R, Spaide RF. Pilot study of enhanced depth imaging optical coherence of tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811-815
17. Imamura Y, Fujiwara, T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469-1473
18. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010;117:1792-1799
19. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina. 2011;31:1603-1608
20. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy. Retina. 2011;21:1921-1927
21. Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2011;151:594-603
22. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249:1123-1128
23. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2010;118:840-845
24. Kim SW, Oh J, Kwon SS, Yoo J, Huh K. Comparison of choroidal thickness among patients with healthy eyes, early age-related macular degeneration, central serous chorioretinopathy and polypoidal vasculopathy. Retina. 2011;31:1904-1911
25. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011; 31:510-517
26. Reibaldi M, Boscia F, Avitabile T, et al. Enhanced depth imaging optical coherence tomography of choroid in idiopathic macular hole: a cross-sectional prospective study. Am J Ophthalmol. 2011;151:112-117
27. Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol. 2004;137:496-503
28. Lafaut BA, Aisenbrey S, Van den Broecke C, Bartz-Schmidt KU, Heimann K. Polypoidal choroidal vasculopathy pattern in agerelated macular degeneration: a clinicopathologic correlation. Retina. 2000;20:650-654
29. Rosa RH Jr, Davis JL, Eifrig CW. Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol. 2002;120:502-508
30. Terasaki H, Miyake Y, Suzuki T, Nakamura M, Nagasaka T. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol. 2002;86:321-327
31. Okubo A, Sameshima M, Uemura A, Kanda S, Ohba N. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol. 2002;86:1093-1098
32. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389
33. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421
34. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and agerelated macular degeneration. Science. 2005;308:421-424
35. Schmidt S, Hauser MA, Scott WK, et al. Cigarette smoking strongly modifies the association of LOC387715 and agerelated macular degeneration. Am J Hum Genet. 2006;78:852-864
36. Hayashi H, Yamashiro K, Gotoh N, et al. CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation. Invest Ophthalmol Vis Sci. 2010;51:5914-5919
37. MacCumber MW, Dastgheib K, Bressler NM, et al. Clinicopathologic correlation of the multiple recurrent serosanguineous retinal pigment epithelial detachments syndrome. Retina. 1994;14:143-152.